Immunology & IBD Strategy Director (Hybrid)

Merck & Co., Inc

United States

Hybrid

USD 173,000 - 273,000

Full time

9 days ago

Application generator

Get a reply from this employer — a resume and cover letter tailored to exactly what they’re hiring for.

Get past ATS filters

Job summary

Merck & Co., Inc. is seeking an experienced immunologist/scientist to join our global competitive intelligence team. The role focuses on IBD expertise to provide scientific, clinical, and commercial insights for portfolio prioritization and BD&L opportunities.

Based in the US with a hybrid work model, the position requires a PhD or equivalent and 8+ years in biotech/pharma, including 3–5+ years in IBD. Travel up to 10% may apply; a comprehensive benefits package is provided.

Qualifications

PhD or equivalent required with 8+ years in biotech/pharma, or MS with 10+ years.
3-5+ years in IBD, immune-mediated inflammatory diseases, or immuno-oncology.
Strong understanding of drug discovery and development processes.

Responsibilities

Provide expert scientific/clinical/commercial insights for prioritization and BD&L.
Collaborate with discovery and clinical teams to shape internal programs.
Monitor IBD therapeutic landscapes and flag threats and opportunities.
Analyze competitor activities and benchmark strategies.
Maintain knowledge of healthcare environment matters including policy and regulation.
Develop a global SME network to support strategic activities.
Support competitive planning for products facing significant events.
Apply ethical and legal standards to CI activities.